VIM and hepatocellular carcinoma: These data demonstrate that expression of CD44 and vimentin correlates with 4EBP1 phosphorylation status in CD44high HCC cells and suggests that inhibiting phosphorylation of 4EBP1 by competitive mTOR inhibitors is a contributing factor to attenuating CD44 expression in HCC cells.